The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, McDonald's is the #12 analyst pick. McDonald's also comes in above the median of analyst picks among the broader S&P 500 index com
The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, McDonald's is the #12 analyst pick. McDonald's also comes in above the median of analyst picks among the broader S&P 500 index com
Two US gasoline traders have departed from Vitol Group , the world’s largest independent commodity trading house. Calvin Greer and Phil Reiser left Vitol’s Houston outpost earlier this month, according to people with knowledge of the situation, asking not to be named as they are not authorized to discuss the matter publicly. Prior to joining Vitol four years ago, Greer worked at trading firm Susqu...
Two US gasoline traders have departed from Vitol Group , the world’s largest independent commodity trading house. Calvin Greer and Phil Reiser left Vitol’s Houston outpost earlier this month, according to people with knowledge of the situation, asking not to be named as they are not authorized to discuss the matter publicly. Prior to joining Vitol four years ago, Greer worked at trading firm Susquehanna International Group, according to his LinkedIn page. At Vitol, Greer worked side-by-side with Reiser, who joined three years ago to trade US Gulf Coast gasoline. Before Vitol, Reiser spent eight years with Exxon Mobil Corp , where he held various roles, including as a gasoline trader. Vitol declined to comment. Greer didn’t immediately return a message seeking comment. Reiser declined to comment. The departures come as senior gasoline trader John Addison, also based in Houston, is retiring. The group is also reorganizing its derivatives desk in London, with some traders likely to leave and others being reassigned to other desks following mark-to-market losses accrued during the early days of the Iran war. Still the energy giant told banks it made a profit of roughly $2 billion in the first quarter as other parts of the business were highly profitable. Read More: Vitol Performed Well Despite ‘Triage’ Early in War, CEO Says
wallix/iStock Editorial via Getty Images Siemens ( SIEGY ) said Monday it was awarded a contract valued at nearly $390M in collaboration with L.K. Comstock, an electrical contractor that specializes in rail transit systems, by the Metropolitan Transportation Authority to modernize New York City's Fulton-Liberty subway lines. Siemens Mobility ( SIEGY ) said it will modernize 23 stations, replace ou...
wallix/iStock Editorial via Getty Images Siemens ( SIEGY ) said Monday it was awarded a contract valued at nearly $390M in collaboration with L.K. Comstock, an electrical contractor that specializes in rail transit systems, by the Metropolitan Transportation Authority to modernize New York City's Fulton-Liberty subway lines. Siemens Mobility ( SIEGY ) said it will modernize 23 stations, replace outdated track circuits, and introduce 5G-based radio communications to power real-time, optimized train control that will make it safe for trains to run as close as 90 seconds apart, replacing century-old infrastructure in Brooklyn and Queens. The scope of work includes the installation and replacement of 24 new special work portions, 94 switch machines, and four new train control rooms; the company said the upgrades require more than 1,200 km of cable to be installed by L.K. Comstock throughout the tunnels and within the newly built facilities. Siemens ( SIEGY ) said it will also take on a 25-year maintenance contract with the option for two additional five-year extensions once the system modernization is complete. The Fulton Line travels through central Brooklyn and connects to the Liberty Line, which begins at Euclid Avenue Station and concludes in Ozone Park, Queens. More on Siemens Siemens: Prospects Appear Baked In For Now Siemens: A Case To Be Made For The Macro-Related Downside Siemens Q1 2026 Earnings Call Presentation
RiverNorthPhotography/iStock Unreleased via Getty Images Operating results ultimately drive long-term returns, but sentiment can be a powerful driver in the near term, and that’s a challenge for Huntington Bancshares Incorporated ( HBAN ) today. A series of negative guidance updates has shaken investor confidence, and there appear to be growing concerns about Huntington’s near-term organic growth ...
RiverNorthPhotography/iStock Unreleased via Getty Images Operating results ultimately drive long-term returns, but sentiment can be a powerful driver in the near term, and that’s a challenge for Huntington Bancshares Incorporated ( HBAN ) today. A series of negative guidance updates has shaken investor confidence, and there appear to be growing concerns about Huntington’s near-term organic growth prospects in increasingly competitive Southeastern banking markets. Moreover, it’s pretty common for institutional investors to steer clear of large-scale M&A stories until the integration process is largely complete. It’s been a while since I’ve updated my thoughts on Huntington’s shares , but the stock has not done especially well in the interim. Up about 25%, HBAN shares have underperformed large bank peers, including rivals leveraged to the Southeast U.S., including Fifth Third ( FITB ), PNC ( PNC ), and Truist ( TFC ). Increasing competition for both loans and deposits is a credible near-term threat, and integrating large acquisitions always carries risk. On top of that, I would not be surprised to see management take another significant swing at M&A to jumpstart its growth ambitions in Southeastern markets like North Carolina. All of that said, I think HBAN screens as one of the cheaper banks, provided that mid-single-digit core earnings growth is a credible target for the long term. Respectable Results To Start The Year The close of the Cadence acquisition in the first quarter renders year-over-year and sequential comparisons largely moot, but Huntington did at least manage to do a little better than expected in terms of core earnings drivers. Revenue was about 1% better than expected, or a little less than $0.01/share relative to sell-side expectations. Net interest income (FTE basis) was about a half-penny shy of expectations, with a weaker net interest margin (3.24% vs. 3.15% in Q4’25 and sell-side expectations of 4.28%) offsetting slightly better than expected ea...
TonyBaggett/iStock Editorial via Getty Images Starbucks ( SBUX ) is scheduled to announce Q2 earnings results on Tuesday, April 28th, after market close. The coffeehouse chain has been undergoing an overhaul, with CEO Brian Niccol highlighting in the recent annual general meeting that the company is ahead of schedule in its turnaround and that “the shine is back on Starbucks.” More recently, Jeffr...
TonyBaggett/iStock Editorial via Getty Images Starbucks ( SBUX ) is scheduled to announce Q2 earnings results on Tuesday, April 28th, after market close. The coffeehouse chain has been undergoing an overhaul, with CEO Brian Niccol highlighting in the recent annual general meeting that the company is ahead of schedule in its turnaround and that “the shine is back on Starbucks.” More recently, Jeffries upgraded the stock to Hold, catalyzed by the franchising of its China business. “We think there is somewhat low visibility into global growth accelerating meaningfully in out years, but the bar/expectations are set low enough,” said Jefferies’ Andy Barish. SA contributor SMR Finance expects the Q2 earnings to “mark an inflection point, with 3–4% comparable sales growth and the first YoY operating margin improvement after eight quarters of contraction.” “Starbucks has outperformed YTD, reflecting growing market optimism about the Niccol-led turnaround and operational improvements,” according to the analysis. Early in the month, contributor Yi Hu, CFA, was more bearish, estimating a margin squeeze despite modest top-line recovery amid macro headwinds and intensifying competition. The consensus EPS Estimate is $0.44 (+7.3% Y/Y), and the consensus revenue estimate is $9.23B (+5.4% Y/Y). Over the last 2 years, SBUX has beaten EPS estimates 0% of the time and has beaten revenue estimates 38% of the time. Over the last 3 months, EPS estimates have seen 9 upward revisions and 2 downward. Revenue estimates have seen 9 upward revisions and 1 downward. More on Starbucks Starbucks Q2 FY26 Results Preview: The Market Is Warming Up To Niccol's Turnaround Starbucks: The Financial Brew Sours Starbucks Corporation (SBUX) Shareholder/Analyst Call - Slideshow Starbucks' $100M Nashville investment fuels speculation over Seattle exit Starbucks adds a ChatGPT twist to the coffee run
According to an SEC filing dated April 27, 2026, Adams Asset Advisors, LLC reduced its holding in Calumet (NASDAQ:CLMT) by 1,954,039 shares during the first quarter of 2026. The estimated value of the shares sold was approximately $50.3 million, based on the average closing price for the quarter. Despite the reduction, the quarter-end value of the Calumet position increased by roughly $12.5 millio...
According to an SEC filing dated April 27, 2026, Adams Asset Advisors, LLC reduced its holding in Calumet (NASDAQ:CLMT) by 1,954,039 shares during the first quarter of 2026. The estimated value of the shares sold was approximately $50.3 million, based on the average closing price for the quarter. Despite the reduction, the quarter-end value of the Calumet position increased by roughly $12.5 million -- a figure that reflects meaningful price appreciation in CLMT shares during the period. Calumet, Inc. manufactures, formulates, and markets a diversified portfolio of specialty-branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. After a nearly 200% run-up in Calumet's share price over the past year, Adams Asset Advisors' decision to trim 1.95 million shares looks a lot like classic profit-taking -- not a loss of faith in the company. Notably, even after the sale, Calumet remains Adams' single largest position, which says a lot about the firm's ongoing conviction. Continue reading
A study of analyst recommendations at the major brokerages shows that McDonald's Corp (Symbol: MCD) is the #12 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. McDonald's Corp also comes in above the median of a
A study of analyst recommendations at the major brokerages shows that McDonald's Corp (Symbol: MCD) is the #12 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. McDonald's Corp also comes in above the median of a
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Uber Technologies Inc (Symbol: UBER) has taken over the #54 spot from PPL Corp (Symbol: PPL), according to ETF Channel. Below is a chart of Uber Technologies Inc ver
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Uber Technologies Inc (Symbol: UBER) has taken over the #54 spot from PPL Corp (Symbol: PPL), according to ETF Channel. Below is a chart of Uber Technologies Inc ver
A study of analyst recommendations at the major brokerages shows that Rio Tinto plc (Symbol: RIO) is the #1 broker analyst pick, on average, out of the 50 stocks making up the Metals Channel Global Mining Titans Index, according to Metals Channel. The Metals Channel Global Mini
A study of analyst recommendations at the major brokerages shows that Rio Tinto plc (Symbol: RIO) is the #1 broker analyst pick, on average, out of the 50 stocks making up the Metals Channel Global Mining Titans Index, according to Metals Channel. The Metals Channel Global Mini
Chip and AI-related stocks were in the red on Monday as investors awaited Big Tech earnings, the upcoming Federal Reserve decision, and developments in the U.S.-Iran war. The tech-focused Nasdaq Composite ( COMP:IND ) dipped around 0.25%. At the same time, the benchmark S&P 500 ( SP500 ) declined about 0.12%. The blue-chip Dow ( DJI ) also fell nearly 0.24%. Tech giants Alphabet ( GOOG ) ( GOOGL )...
Chip and AI-related stocks were in the red on Monday as investors awaited Big Tech earnings, the upcoming Federal Reserve decision, and developments in the U.S.-Iran war. The tech-focused Nasdaq Composite ( COMP:IND ) dipped around 0.25%. At the same time, the benchmark S&P 500 ( SP500 ) declined about 0.12%. The blue-chip Dow ( DJI ) also fell nearly 0.24%. Tech giants Alphabet ( GOOG ) ( GOOGL ), Microsoft ( MSFT ), Amazon ( AMZN ), and Meta Platforms ( META ) are slated to report results on Wednesday, while Apple ( AAPL ) reports on Thursday. Iran has offered to end its stronghold on the Strait of Hormuz in exchange for the U.S. lifting its blockade on the country and an end to the war, The Associated Press reported on Monday, citing two regional officials. Iran’s Foreign Minister Abbas Araghchi was in Russia on Monday for a meeting with President Vladimir Putin as part of a trip that included two stops in Pakistan, where leaders are trying to restart stalled talks between Iran and the U.S. Reportedly, at least seven ships — mainly dry bulk vessels — have crossed the Strait of Hormuz in the past 24 hours, as the vital waterway remains effectively shut to international shipping. Separately, Adrian Bisserie, CEO of Ducat Maritime noted that the disruptions in the Strait of Hormuz are creating inflationary pressures equivalent to roughly half of what was seen during the COVID-19 pandemic. Brent Futures ( CO1:COM ) jumped about 3.17%, while Crude Oil Futures ( CL1:COM ) climbed nearly 2.97% on Monday. Shares of AI chipmaker Nvidia ( NVDA ) climbed about 1%, while Advanced Micro Devices ( AMD ) fell nearly 4%. Broadcom ( AVGO ) declined around 2%, while Qualcomm ( QCOM ) was also in the red. Several other AI and networking-related stocks were in the red. Applied Optoelectronics ( AAOI ) plummeted about 10%, while Coherent ( COHR ) and Lumentum ( LITE ) each tumbled nearly 5%. Corning ( GLW ) and Arista Networks ( ANET ) each slumped about 4%, while Ciena ( CIEN ) fel...
Sam Altman and Elon Musk are set to face off in a high-stakes trial that could alter the future of tech’s leading AI startup, OpenAI. The trial begins with jury selection on April 27th, as Musk pushes forward his 2024 lawsuit that accuses OpenAI of abandoning its founding mission of developing AI to benefit humanity and shifting focus to boosting profits instead. Musk was a cofounder of OpenAI and...
Sam Altman and Elon Musk are set to face off in a high-stakes trial that could alter the future of tech’s leading AI startup, OpenAI. The trial begins with jury selection on April 27th, as Musk pushes forward his 2024 lawsuit that accuses OpenAI of abandoning its founding mission of developing AI to benefit humanity and shifting focus to boosting profits instead. Musk was a cofounder of OpenAI and claims that Altman and co-founder Greg Brockman tricked him into giving the company money, only to turn their backs on their original goal. However, OpenAI says that “This lawsuit has always been a baseless and jealous bid to derail a competitor” in a bid to boost Musk’s own SpaceX / xAI / X companies that have launched Grok as a competitor to ChatGPT. In his lawsuit, Musk is asking for the removal of Altman and Brockman , and for OpenAI to stop operating as a public benefit corporation. Musk has also demanded that OpenAI’s nonprofit receive up to $150 billion in damages he’s asking for if he wins the case. Here’s all the latest on the trial between Musk and Altman: The Elon Musk vs. OpenAI trial starts today. Elon Musk drops fraud claims against OpenAI and Sam Altman before trial. Elon Musk is about to be a very busy boy! ‘Sideshow’ concerns and billionaire dreams: What I learned from Elon Musk’s lawsuit against OpenAI Elon Musk’s xAI is suing OpenAI and Apple Inside Elon Musk’s messy breakup with OpenAI Elon Musk is suing OpenAI and Sam Altman again
Nebius (NASDAQ: NBIS) just signed massive AI cloud deals that could completely change its growth story, but the stock now faces a tougher question. Can management scale fast enough to justify the hype, or are expectations already running too hot? Stock prices used were the market prices of April 22, 2026. The video was published on April 26, 2026. Continue reading
Nebius (NASDAQ: NBIS) just signed massive AI cloud deals that could completely change its growth story, but the stock now faces a tougher question. Can management scale fast enough to justify the hype, or are expectations already running too hot? Stock prices used were the market prices of April 22, 2026. The video was published on April 26, 2026. Continue reading
1001Love/iStock via Getty Images Investment Overview - White House / FDA Take Steps To Fast-Track Approval Of Psychedelic Depression Meds Last Monday, in a note for Seeking Alpha , I covered the company GH Research ( GHRS ), based in Dublin, Ireland, and focused on the development of two drug candidates derived from mebufotenin (5-MeO-DMT), a rapid-acting psychedelic drug and serotonin agonist. I ...
1001Love/iStock via Getty Images Investment Overview - White House / FDA Take Steps To Fast-Track Approval Of Psychedelic Depression Meds Last Monday, in a note for Seeking Alpha , I covered the company GH Research ( GHRS ), based in Dublin, Ireland, and focused on the development of two drug candidates derived from mebufotenin (5-MeO-DMT), a rapid-acting psychedelic drug and serotonin agonist. I noted the >50% rise in the company's share price across the past month and explained that these gains were driven by the news that U.S. President Trump would be signing an executive order aimed at accelerating research and expanding access to substances used abroad to treat post-traumatic stress disorder. A White House statement noted that over 14m American adults have a serious mental illness, with 8m currently taking prescription medicine, that suicide rates had increased by 37% between 2000 and 2018, and that veterans "suffer in greater measure from this tragedy," and that: Psychedelic drugs, including ibogaine compounds, show potential in clinical studies to address serious mental illnesses for patients whose conditions persist after completing standard therapy. Indeed, the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to specific psychedelic drugs, and there are numerous products currently in the clinical trial pipeline for review of safety and efficacy. It is the policy of my Administration to accelerate innovative research models and appropriate drug approvals to increase access to psychedelic drugs that could save lives and reverse the crisis of serious mental illness in America. The Executive Order makes several pledges, perhaps most crucially, that: The Commissioner of Food and Drugs shall provide Commissioner’s National Priority Vouchers to appropriate psychedelic drugs that have received a Breakthrough Therapy designation and are in accordance with the criteria of the National Priority Voucher Program. This could potentially see...
Shareholders of Cracker Barrel Old Country Store Inc (Symbol: CBRL) looking to boost their income beyond the stock's 3.3% annualized dividend yield can sell the January 2027 covered call at the $42.50 strike and collect the premium based on the $2.70 bid, which annualizes to an
Shareholders of Cracker Barrel Old Country Store Inc (Symbol: CBRL) looking to boost their income beyond the stock's 3.3% annualized dividend yield can sell the January 2027 covered call at the $42.50 strike and collect the premium based on the $2.70 bid, which annualizes to an
RealityMine®, a global leader in privacy-first digital behavioural data, has been named winner of the Global Ambition award at the Northern Tech Awards — recognising the company as the standout international player among 100 of the UK's most ambitious tech firms. The win comes as demand surges for richer, more accurate insight into how consumers behave in the digital world.
RealityMine®, a global leader in privacy-first digital behavioural data, has been named winner of the Global Ambition award at the Northern Tech Awards — recognising the company as the standout international player among 100 of the UK's most ambitious tech firms. The win comes as demand surges for richer, more accurate insight into how consumers behave in the digital world.